The pathogenesis of idiopathic sensory ganglionopathy.

  • Research type

    Research Study

  • Full title

    Investigations into the possible antibody mediated causes of idiopathic sensory ganglionopathy

  • IRAS ID

    149378

  • Contact name

    Michael Kin Loon Chou

  • Contact email

    michael.chou@uclh.nhs.uk

  • Sponsor organisation

    UCL

  • Clinicaltrials.gov Identifier

    No Z6364106/2016/09/01 , DPA

  • Duration of Study in the UK

    7 years, 0 months, 1 days

  • Research summary

    The aim of this research is to try and understand what may cause idiopathic sensory ganglionopathy (SG).

    SG is an uncommon disease that can lead to various degrees of disability and is commonly seen as occurring due to another disease. Most have an unknown cause and progress slowly and irreversibly even with treatment.

    By analysing samples from patients seen at the National Hospital for Neurology and Neurosurgery as part of their treatment, we will try and find the cause of idiopathic sensory ganglionopathy. Previous work suggests it may be an immune system disorder leading to nerve problems.

    Inclusion criteria: All patients must have been clinically defined as having SG without any known cause.

    Control patients will be age matched and in three groups. One group will be normal, the second group will be patients with motor neuropathy and a third group of patients will be other neuropathies.

    Protein studies will be used to help the investigations into these patients to identify any proteins involved in the disease.

    These proteins will be examined further by mass spectrometry (MS). Other experiments will help us define more accurately possible causes of idiopathic sensory ganglionopathy.

  • REC name

    North East - Tyne & Wear South Research Ethics Committee

  • REC reference

    17/NE/0211

  • Date of REC Opinion

    7 Jul 2017

  • REC opinion

    Favourable Opinion